One Wealth Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-70
Closed -$35.9K 317
2022
Q4
$35.9K Buy
+70
New +$35.5K 0.01% 458
2019
Q2
Sell
-787
Closed -$226K 222
2019
Q1
$226K Buy
787
+23
+3% +$6.65K 0.18% 94
2018
Q4
$201K Sell
764
-205
-21% -$56.4K 0.2% 93
2018
Q3
$266K Sell
969
-69
-7% -$17.9K 0.2% 98
2018
Q2
$247K Sell
1,038
-102
-9% -$23.6K 0.2% 105
2018
Q1
$250K Sell
1,140
-15
-1% -$3.52K 0.22% 91
2017
Q4
$260K Buy
+1,155
New +$246K 0.21% 80

Other funds holding ELV

One Wealth Advisors's ELV Position: Q1 2023 in Review

One Wealth Advisors sold out of Elevance Health (ELV) in Q1 2023, closing a stake of 70 shares — an estimated $35.9K sold.

One Wealth Advisors first reported a position in ELV in Q4 2017 and held it in 7 quarters. The position peaked at $266K in Q3 2018. 1,516 funds tracked by Wall St. Rank hold ELV as of Q1 2023.

  • One Wealth Advisors reported no remaining Elevance Health position as of Q1 2023 after selling out during the quarter.
  • One Wealth Advisors sold 70 Elevance Health shares in Q1 2023, an estimated $35.9K.
  • One Wealth Advisors first reported a position in Elevance Health in Q4 2017 and held it in 7 quarters.
  • One Wealth Advisors's Elevance Health position peaked at $266K in Q3 2018.
  • 1,516 funds tracked by Wall St. Rank held Elevance Health as of Q1 2023.

Based on One Wealth Advisors's 13F filing for Q1 2023, filed 15 May 2023.